Article
High-dose (9 MU) long-term (60 weeks) alfa-interferon therapy for chronic hepatitis patients infected with HCV genotype 1b.
Archives of virology - 1 Jan 1998
Kanai K, Kako M, Kumada T, Tsubouchi H, Aikawa T, Kojima M, Harada H, Kawasaki T, Nakashima M, Okamoto H, Mishiro S
Abstract excerpt
Efficacy of standard regimens (e.g., 3-6 MU for 24 weeks) of alfa-IFN therapy for chronic hepatitis C has been limited, particularly in patients with HCV/1b. To see if higher-dose longer term treatment is more effective, we tried a 9 MU 60-week regimen. HCV/1b-infected chronic hepatitis patients...
Topics
- Genotype
- Hepacivirus
- Hepatitis C, Chronic
- Humans
- Interferon alpha-2
- Interferon-alpha
- Recombinant Proteins